Announcing the Launch of the This Week in Policy and Medicine Podcast
We are excited to announce the debut of the This Week in Policy and Medicine Podcast, a weekly series that brings you the latest…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
HHS OIG
CMS Proposes Changes to Reporting and Returning Medicare Parts A and B…
Tucked into the Physician Fee Schedule is a provision that should be of interest to False Claims Act attorneys. Regarding Medicare…
Policy and Medicine Compliance Update August 2023 Issue Features: CMS Open…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Policy and Medicine Compliance Update April 2023 Issue Features: DOJ’s…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Allergan Botox Settlement and Corporate Integrity Agreement
This week, the United States Department of Justice (DOJ) announced that it has reached a resolution regarding the previously…
Ortho-McNeil Settlement and Corporate Integrity Agreement
Last week was not the only settlement agreement (AstraZeneca) signed between a pharmaceutical company and the Office of…
Astra Zeneca Seroquel Settlement and Corporate Integrity Agreement
Under the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in its new drug application to the…
Letters from Grassley: CDC Send Us Your Advisors Names
Last year, a report by the Department of Health and Human Services (HHS) Office of the Inspector General (OIG), noted that “the US…
HHS OIG Report on CDC COI Forms: A Case of Different Priorities
According to a report by the Department of Health and Human Services…
Pfizer: $2.3 Billion Settlement and Corporate Integrity Agreement
Pfizer Inc today announced a finalized settlement with the Department of Justice (DOJ) regarding an investigation into past…